MLH1 and MSH2 as Potential Biomarkers of Risk for Colorectal Cancer

MLH1 and MSH2 as Potential Biomarkers of Risk for Colorectal Cancer


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 4,396

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Colorectal cancer is the third most common incident cancer in the United States and the second cause of cancer deaths in men and women combined. Impairment of DNA mismatch repair (MMR) mechanisms in colonocytes is responsible for about 15% of colorectal cancers. MLH1 and MSH2 proteins play a crucial role in DNA MMR and loss of expression of either (or both) of these proteins is the main cause of DNA MMR insufficiency. These pilot data suggest that lower MLH1 and MSH2 expression in the normal colonic mucosa, at least in the ascending colon, may be associated with increased risk of incident, sporadic colorectal adenoma as well as with modifiable risk factors for colorectal neoplasms, specifically, regular use of NSAIDs. Higher calcium and vitamin D intakes result in increased DNA MMR system activity in the normal colorectal mucosa of sporadic adenoma patients, and the strongest effects may be vitamin D related. These data support further investigation of MLH1 and MSH2 expression as potential modifiable biomarkers of risk for colorectal neoplasms. This work would be interesting for molecular epidemiologists and cancer researchers.

Product Specifications
SKU :COC27896
Country of Manufacture
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29
0 Review(s)